Epinephrine and Riboflavin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Epinephrine (epinephrine) and Riboflavin (riboflavin (vitamin b2)). Common drug interactions include bronchiectasis among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Epinephrine and Riboflavin. It is created by eHealthMe based on reports of 73 people who take the same drugs from the FDA, and is updated regularly.

What is Epinephrine?

Epinephrine has active ingredients of epinephrine. It is often used in asthma. eHealthMe is studying from 21,290 Epinephrine users. Check the latest studies of Epinephrine.

What is Riboflavin?

Riboflavin has active ingredients of riboflavin (vitamin b2). It is often used in migraine. eHealthMe is studying from 2,869 Riboflavin users. Check the latest studies of Riboflavin.



On Jul, 13, 2026

73 people who take Epinephrine and Riboflavin together, and have interactions are studied.

Epinephrine and Riboflavin drug interactions.

What are the common drug interactions of Epinephrine and Riboflavin, by gender? *:

female:

  1. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  2. Sinusitis (inflammation of sinus)
  3. Nausea (feeling of having an urge to vomit)
  4. Ear infection
  5. Headache (pain in head)
  6. Cellulitis (infection under the skin)
  7. Fatigue (feeling of tiredness)
  8. Seasonal allergy (allergic condition due to certain season)
  9. Cystitis (inflammation of the wall of the bladder)
  10. Dizziness

male:

  1. Cough
  2. Drug ineffective
  3. Lactic acidosis (low ph in body tissues)
  4. Pneumonia
  5. Respiratory failure (inadequate gas exchange by the respiratory system)
  6. Surgery
  7. Viral infection
  8. Dyspnoea (difficult or laboured respiration)
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Epinephrine and Riboflavin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cellulitis (infection under the skin)
  2. Infusion related reaction
  3. Bone tuberculosis
  4. Cardiac murmur (an heart sound in valve abnormality)
  5. Diarrhoea
  6. Dizziness
  7. Dyspnoea (difficult or laboured respiration)
  8. Fall
  9. Nasal discomfort
  10. Nasal inflammation (inflammation of nose)

20-29:

  1. Sinusitis (inflammation of sinus)
  2. Anal infection
  3. Ear infection
  4. Gallbladder disorder
  5. Lymphadenitis (inflammation or enlargement of a lymph node)
  6. Middle ear effusion (fluid in middle ear)
  7. Peripheral swelling
  8. Postoperative wound infection
  9. Sexual abuse
  10. Upper respiratory tract infection

30-39:

  1. Drug ineffective
  2. Fatigue (feeling of tiredness)
  3. Headache (pain in head)
  4. Hypotension (abnormally low blood pressure)
  5. Hypoxia (low oxygen in tissues)
  6. Infusion related reaction
  7. Lactic acidosis (low ph in body tissues)
  8. Peripheral swelling
  9. Phlebitis (inflammation of the walls of a vein)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

40-49:

  1. Weight increased
  2. Sinusitis (inflammation of sinus)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Cellulitis (infection under the skin)
  5. Headache (pain in head)
  6. Infection
  7. Infusion site haematoma (localized swelling filled with blood at infusion site)
  8. Infusion site mass
  9. Infusion site rash
  10. Skin infection

50-59:

  1. Cardiac disorder
  2. Cardiomegaly (increased size of heart than normal)
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Chest discomfort
  5. Chest pain
  6. Chills (felling of cold)
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Cough
  9. Cyst (a closed sac)
  10. Decreased appetite

60+:

  1. Fall
  2. Pneumonia
  3. Ear infection
  4. Eye disorder
  5. Headache (pain in head)
  6. Heart rate increased
  7. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  8. Joint injury
  9. Peripheral swelling
  10. Road traffic accident

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 33 people, 45.21%
  2. Primary Immunodeficiency Syndrome: 7 people, 9.59%
  3. Immune System Disorder: 6 people, 8.22%
  4. Petit Mal Epilepsy (absence seizure): 4 people, 5.48%
  5. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 4 people, 5.48%

* Approximation only. Some reports may have incomplete information.

Do you take Epinephrine and Riboflavin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Epinephrine and Riboflavin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Epinephrine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Riboflavin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Epinephrine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Riboflavin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on epinephrine and riboflavin (vitamin b2) (the active ingredients of Epinephrine and Riboflavin, respectively), and Epinephrine and Riboflavin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: